Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (951,880)	$ (2,743,206)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	38,856	40,406
Stock-based compensation	13,593	46,281
Amortization of discount on debt and deferred financing costs	23,094	286,313
Loss on extinguishment of debt		257,775
Change in fair value of warrant liability	136,605	1,228,703
Change in fair value of derivative liabilities	(6,246)	179,952
Issuance of common stock for consulting services	22,900	330,000
Changes in operating assets and liabilities:
Accounts receivable	384	(482)
Inventory	(6,624)	1,721
Prepaid expenses and other current assets	472,077	(2,999)
Accounts payable	41,433	63,072
Accrued expenses	161,460	101,911
Net cash used in operating activities	(54,348)	(210,553)
Cash flows from investing activities:
Net cash on acquisition		3,592
Net cash provided by investing activities		3,592
Cash flows from financing activities:
Cash received from issuance of related party notes payable	50,000
Proceeds from issuance of preferred stock		275,000
Net cash provided by financing activities	50,000	275,000
Net (decrease) increase in cash	(4,348)	68,039
Cash, beginning of period	12,467	137,279
Cash, end of period	8,119	205,318
Cash paid during the period for:
Interest
Income taxes
Non-cash financing activities:
Conversion of convertible notes payable and accrued interest into common stock		1,091,784
Derivative liability associated with preferred stock		226,833
Issuance of common stock for the acquisition of CureDM Group Holdings LLC		1,250,000
Contingent liability shares and goodwill in acquisition of CureDM Groups Holdings LLC		$ 1,137,057